145 related articles for article (PubMed ID: 7613557)
1. Poisson regression analysis in clinical research.
Kianifard F; Gallo PP
J Biopharm Stat; 1995 Mar; 5(1):115-29. PubMed ID: 7613557
[TBL] [Abstract][Full Text] [Related]
2. Analyzing counts, durations, and recurrences in clinical trials.
McIntosh J
J Biopharm Stat; 2001; 11(1-2):65-74. PubMed ID: 11459443
[TBL] [Abstract][Full Text] [Related]
3. Modeling zero-inflated count data when exposure varies: With an application to tumor counts.
Baetschmann G; Winkelmann R
Biom J; 2013 Sep; 55(5):679-86. PubMed ID: 24003010
[TBL] [Abstract][Full Text] [Related]
4. A general family of distributions for longitudinal dependence with special reference to event histories.
Lindsey JK
Stat Med; 2001 Jun; 20(11):1625-38. PubMed ID: 11391692
[TBL] [Abstract][Full Text] [Related]
5. A flexible count data regression model for risk analysis.
Guikema SD; Coffelt JP
Risk Anal; 2008 Feb; 28(1):213-23. PubMed ID: 18304118
[TBL] [Abstract][Full Text] [Related]
6. Testing approaches for overdispersion in poisson regression versus the generalized poisson model.
Yang Z; Hardin JW; Addy CL; Vuong QH
Biom J; 2007 Aug; 49(4):565-84. PubMed ID: 17638291
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the performance of the Conway-Maxwell Poisson generalized linear model.
Francis RA; Geedipally SR; Guikema SD; Dhavala SS; Lord D; LaRocca S
Risk Anal; 2012 Jan; 32(1):167-83. PubMed ID: 21801191
[TBL] [Abstract][Full Text] [Related]
8. Group sequential procedures for repeated events data with frailty.
Jiang W
J Biopharm Stat; 1999 Aug; 9(3):379-99. PubMed ID: 10473027
[TBL] [Abstract][Full Text] [Related]
9. The analysis of count data: a gentle introduction to poisson regression and its alternatives.
Coxe S; West SG; Aiken LS
J Pers Assess; 2009 Mar; 91(2):121-36. PubMed ID: 19205933
[TBL] [Abstract][Full Text] [Related]
10. Sample size for comparing linear growth curves.
Patel HI; Rowe E
J Biopharm Stat; 1999 May; 9(2):339-50. PubMed ID: 10379697
[TBL] [Abstract][Full Text] [Related]
11. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
[TBL] [Abstract][Full Text] [Related]
12. Statistical analysis of clinical trials.
Wassertheil-Smoller S; Kim MY
Semin Nucl Med; 2010 Sep; 40(5):357-63. PubMed ID: 20674595
[TBL] [Abstract][Full Text] [Related]
13. A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.
Li J; Yang X; Wu Y; Shoptaw S
Stat Med; 2007 May; 26(12):2519-32. PubMed ID: 17106918
[TBL] [Abstract][Full Text] [Related]
14. Extension of the application of conway-maxwell-poisson models: analyzing traffic crash data exhibiting underdispersion.
Lord D; Geedipally SR; Guikema SD
Risk Anal; 2010 Aug; 30(8):1268-76. PubMed ID: 20412518
[TBL] [Abstract][Full Text] [Related]
15. A generalized estimating equation approach for modeling random length binary vector data.
Albert PS; Follmann DA; Barnhart HX
Biometrics; 1997 Sep; 53(3):1116-24. PubMed ID: 9290230
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of continuous outcome data from individual patients.
Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
[TBL] [Abstract][Full Text] [Related]
17. Application of the Conway-Maxwell-Poisson generalized linear model for analyzing motor vehicle crashes.
Lord D; Guikema SD; Geedipally SR
Accid Anal Prev; 2008 May; 40(3):1123-34. PubMed ID: 18460381
[TBL] [Abstract][Full Text] [Related]
18. A new approach for handling longitudinal count data with zero-inflation and overdispersion: poisson geometric process model.
Wan WY; Chan JS
Biom J; 2009 Aug; 51(4):556-70. PubMed ID: 19650053
[TBL] [Abstract][Full Text] [Related]
19. Ignoring overdispersion in hierarchical loglinear models: Possible problems and solutions.
Milanzi E; Alonso A; Molenberghs G
Stat Med; 2012 Jun; 31(14):1475-82. PubMed ID: 22362329
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
Byar D; Blackard C
Urology; 1977 Dec; 10(6):556-61. PubMed ID: 414402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
